comprehensive -WSS

comprehensive

author：fashion 2025-09-28 00:51:21 - browse：76

Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Future doctors need a strong humanities education

leisure time

hotspot

WSS

Bird flu surveillance in wastewater gets boost from consortium

Immunocompromised patients offer clues on chronic Covid

FDA sets aggressive timeline for overhauling inspection procedures

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

HPV vaccine, cervical cancer study delivers historic results

Eyeing GLP

Wikipedia

comprehensive

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

H5N1 virus can be tracked in retail milk, scientists say

Medicare details structure of new drug price negotiation program

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

United colonoscopy coverage change 'may cost lives,' doctors say

TikTok, Instagram influencers need more rules for drug ads

The cancer drug shortage isn’t new — and neither are the solutions

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Apple is now the first public company to be valued at $3 trillion

Inaction leaves children at risk from dangerous chemotherapy drug

knowledge

Eyeing GLP

Update the Apgar Score to remove skin color

As a primary care physician, here's how I hope to partner with AI

Addressing health care workers' trauma can help fight burnout

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Investigation reveals sickle cell patients pressured into sterilizations

Wikipedia

leisure time

hotspot

focus